Skip to main content
. 2022 Oct 18;12(12):2691–2703. doi: 10.1007/s13555-022-00829-4
The burden of atopic dermatitis on children is considerable; it may have a significant impact on a patient’s health and quality of life.
The pathophysiology of atopic dermatitis is complex, involving factors such as genetics, an altered immune response, and the environment. As a result, there are a variety of therapeutic targets to consider.
Patients may utilize conventional pharmaceuticals or over-the-counter therapies to manage their symptoms, the choice of which often depends on the severity of disease.
Those with refractory cases or those who prefer another treatment option may consider an alternative treatment approach.
New strategies have emerged for pediatric atopic dermatitis over the past few years, and as advancements are made in research, novel therapies are likely to soon be introduced.